本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fulcrum Therapeutics

3.79
-0.0100-0.26%
盤後3.800.0100+0.26%18:08 EDT
成交量:70.65萬
成交額:267.76萬
市值:2.89億
市盈率:-3.13
高:3.82
開:3.82
低:3.78
收:3.80
52周最高:15.74
52周最低:2.83
股本:7,629.73萬
流通股本:6,349.06萬
量比:0.63
換手率:1.11%
股息:- -
股息率:- -
每股收益(TTM):-1.2104
每股收益(LYR):-1.1819
淨資產收益率:-32.38%
總資產收益率:-19.59%
市淨率:0.93
市盈率(LYR):-3.21

資料載入中...

2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/18

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/17

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/17

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/25

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report